[3,4-(13)C(2)]-CHENODEOXYCHOLIC-ACID
Compound with spectra: 1 NMR
![[3,4-(13)C(2)]-CHENODEOXYCHOLIC-ACID](/api/compound/9vSQgUqQgqm.png?ph=true&h=300&w=458 "[3,4-(13)C(2)]-CHENODEOXYCHOLIC-ACID")
| SpectraBase Compound ID | 9vSQgUqQgqm |
|---|---|
| InChI | InChI=1S/C23H38O4/c1-13(3-8-21(26)27)16-4-5-18-17(16)6-7-19-22(18)20(25)12-14-11-15(24)9-10-23(14,19)2/h13-20,22,24-25H,3-12H2,1-2H3,(H,26,27)/t13-,14-,15+,16+,17+,18+,19-,20+,22-,23-/m0/s1/i11+1,15+1 |
| InChIKey | CILFZDDLSHDCJG-ANRXWNLLSA-N |
| Mol Weight | 380.5 g/mol |
| Molecular Formula | C2113C2H38O4 |
| Exact Mass | 380.283719 g/mol |
| Enantiomer InChIKey | CILFZDDLSHDCJG-KPDKSTJGSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
[3,4-(13)C(2)]-CHOLIC-ACID
[3,4-(13)C(2)]-DEOXYCHOLIC-ACID
SQUALAMINE
3.beta.-[(t-Butyldimethylsilyl)oxy]-26-(pivaloyloxy)cholest-5.alpha.-an-7-ol
(5R,7R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(1R)-1-methylpropyl]spiro[1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxane]-7-ol
3.beta.,26-bis[(t-Butyldimethyl)silyloxy]-5.alpha.-cholestan-7.beta.-ol
(6R)-6-[(3S,5R,7R,8R,9S,10S,13R,14S)-3-[3-(4-aminobutylamino)propylamino]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-1-en-3-one
JYYWYWMQJFVWIH-AZYLGJTNSA-N
3-BETA,12-ALPHA-DIHYDROXY-5-BETA-CHOLSAEUREMETHYLESTER
3-BETA,12-BETA-DIHYDROXY-5-BETA-CHOLSAEUREMETHYLESTER
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of [3,4-13C2]-Enriched Bile Salts as NMR Probes of Protein−Ligand Interactions | The Journal of Organic Chemistry | 2002 |